Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor
OwnerTomokazu Nagano, Ikue Kudo +5inventors
InventorsTomokazu Nagano, Ikue Kudo, Takao Kawamura, Mutsuo Taiji, Hiroshi Noguchi, Shunsuke Tani, Hiroo Maeda
Life of this patent
Estimating the term…
Abstract
Preparations to be administered for treating or preventing ischemic diseases or arterial diseases which contain Hepatocyte growth factor (HGF) as an active ingredient. The preparations provide such effect that HGF concentration in an affected region to which HGF was administered is maintained, a half-life is longer, a dose can be reduced, and other organs except the affected region are less affected in comparison with intravenous administration.
Claims3
A method for treating ischemic disease of heart or limbs in a patient in need thereof, comprising:
- intramuscularly administering to a patient suffering from said ischemic disease, an effective amount of a composition comprising Hepatocyte Growth Factor (HGF) as an active ingredient,
- wherein the composition is transported to, distributed in, and acts on tissues that are local to or around the region of administration, wherein a maximum concentration of said composition in the blood, liver and kidney is a hundredth or less, and a concentration in said muscle is at least 50 times greater than when said composition is administered by intravenous bolus administration, and
- wherein the composition has reduced transportation to, distribution in, and effect in blood or bodily organs other than those that are local to said region of administration,
- thereby treating said ischemic disease of heart or limbs.
A method for treating ischemic disease of heart or limbs in a patient in need thereof, comprising:
- intramuscularly administering to a patient suffering from said ischemic disease, an effective amount of a composition comprising Hepatocyte Growth Factor (HGF) as an active ingredient,
- wherein the composition is transported to, distributed in, and acts on tissues that are local to or around the region of administration, wherein AUC in the blood, liver and kidney is a fifth or less, and AUC in said muscle is at least 50 times greater than when said composition is administered by intravenous bolus administration, and
- wherein the composition has reduced transportation to, distribution in, and effect in blood or bodily organs other than those that are local to said region of administration,
- thereby treating said ischemic disease of heart or limbs.
A method for treating ischemic disease of heart or limbs in a patient in need thereof, comprising:
- intramuscularly administering to a patient suffering from said ischemic disease, an effective amount of a composition comprising Hepatocyte Growth Factor (HGF) as an active ingredient,
- wherein the composition is transported to, distributed in, and acts on tissues that are local to or around the region of administration and wherein said composition is administered at a dose of is 0.1 to 10 μg/kg, and
- wherein the composition has reduced transportation to, distribution in, and effect in blood or bodily organs other than those that are local to said region of administration,
- thereby treating said ischemic disease of heart or limbs.
Dependencies are inferred from the claim text.